-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Povorcitinib Phosphate in Hidradenitis Suppurativa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Povorcitinib Phosphate in Hidradenitis Suppurativa report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Povorcitinib Phosphate in Hidradenitis Suppurativa Drug Details: Povorcitinib (INCB-54707) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ezurpimtrostat in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ezurpimtrostat in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ezurpimtrostat in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: Ezurpimtrostat (GNS-561)...
-
Product Insights
Ascites – Drugs In Development, 2023
Global Markets Direct’s, ‘Ascites - Drugs In Development, 2023’, provides an overview of the Ascites pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ascites, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Hepatic Encephalopathy – Drugs In Development, 2023
Global Markets Direct’s, ‘Hepatic Encephalopathy - Drugs In Development, 2023’, provides an overview of the Hepatic Encephalopathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hepatic Encephalopathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Acute On Chronic Liver Failure (ACLF) – Drugs In Development, 2023
Global Markets Direct’s, ‘Acute On Chronic Liver Failure (ACLF) - Drugs In Development, 2023’, provides an overview of the Acute On Chronic Liver Failure (ACLF) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute On Chronic Liver Failure (ACLF), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
Acute Liver Failure – Drugs In Development, 2023
Global Markets Direct’s, ‘Acute Liver Failure - Drugs In Development, 2023’, provides an overview of the Acute Liver Failure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Liver Failure, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Liver Failure (Hepatic Insufficiency) – Drugs In Development, 2023
Global Markets Direct’s, ‘Liver Failure (Hepatic Insufficiency) - Drugs In Development, 2023’, provides an overview of the Liver Failure (Hepatic Insufficiency) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Liver Failure (Hepatic Insufficiency), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...